Authors: PENDERGRASS KB

Citation: Kb. Pendergrass, OPTIONS IN THE TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS, Cancer practice, 6(5), 1998, pp. 276-281

Authors: PENDERGRASS KB MODIANO MR OTSUKA A RIZVI N CHERNOFF SB

Citation: Kb. Pendergrass et al., DOLASETRON (DOL) TABLETS ARE HIGHLY EFFECTIVE IN PREVENTING HIGH-DOSECISPLATIN-INDUCED EMESIS, Annals of oncology, 9, 1998, pp. 691-691

Authors: GROTE TH PINEDA LF FIGLIN RA PENDERGRASS KB HESKETH PJ KARLAN BY REEVES JA PORTER LL BENEDICT CR HAHNE WF

Citation: Th. Grote et al., ORAL DOLASETRON MESYLATE IN PATIENTS RECEIVING MODERATELY EMETOGENIC PLATINUM-CONTAINING CHEMOTHERAPY, The cancer journal from Scientific American, 3(1), 1997, pp. 45-51

Authors: KRIS MG PENDERGRASS KB NAVARI RM GROTE TH NELSON AM THOMAS V FERGUSON BB ALLMAN DS PIZZO BA BAKER TW FERNANDO IJ CHERNOFF SB

Citation: Mg. Kris et al., PREVENTION OF ACUTE EMESIS IN CANCER-PATIENTS FOLLOWING HIGH-DOSE CISPLATIN WITH THE COMBINATION OF ORAL DOLASETRON AND DEXAMETHASONE, Journal of clinical oncology, 15(5), 1997, pp. 2135-2138

Authors: JONES DV WINN RJ BROWN BW LEVY LB PUGH RP WADE JL GROSS HM PENDERGRASS KB LEVIN B ABBRUZZESE JL

Citation: Dv. Jones et al., RANDOMIZED PHASE-III STUDY OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID VERSUS 5-FLUOROURACIL PLUS FOLINIC ACID PLUS METHYL-LOMUSTINE FOR PATIENTS WITH ADVANCED COLORECTAL-CANCER, Cancer, 76(10), 1995, pp. 1709-1714